Litcius/Paper detail

When Direct Oral Anticoagulants Should Not Be Standard Treatment

Antoine Bejjani, Candrika D. Khairani, Ali Assi, Gregory Piazza, Parham Sadeghipour, Azita H. Talasaz, John Fanikos, Jean M. Connors, Deborah Siegal, Geoffrey D. Barnes, Karlyn A. Martin, Dominick J. Angiolillo, Dawn Kleindorfer, Manuel Monréal, David Jiménez, Saskia Middeldorp, Mitchell S.V. Elkind, Christian T. Ruff, Samuel Z. Goldhaber, Harlan M. Krumholz, Roxana Mehran, Mary Cushman, John W. Eikelboom, Gregory Y.H. Lip, Jeffrey I. Weitz, Renato D. Lópes, Behnood Bikdeli

2024Journal of the American College of Cardiology71 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAtrial fibrillationStroke (engine)CardiologyThrombusRandomized controlled trialInternal medicineThrombosisIntensive care medicineEngineeringMechanical engineeringAtrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementCardiac Arrhythmias and Treatments
When Direct Oral Anticoagulants Should Not Be Standard Treatment | Litcius